Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial

被引:6
|
作者
Donahue, Sean P.
Recchia, Franco
Sternberg, Paul, Jr.
机构
关键词
D O I
10.1016/j.ajo.2010.04.006
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:287 / 287
页数:1
相关论文
共 50 条
  • [1] Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
    Subramanian, Manju L.
    Ness, Steven
    Abedi, Gelareh
    Ahmed, Ednan
    Daly, Mary
    Feinberg, Edward
    Bhatia, Sumit
    Patel, Payal
    Nguyen, Maileah
    Houranieh, Antoun
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 148 (06) : 875 - 882
  • [2] Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial
    Subramanian, M. L.
    Abedi, G.
    Ness, S.
    Ahmed, E.
    Fenberg, M.
    Daly, M. K.
    Houranieh, A.
    Feinberg, E. B.
    EYE, 2010, 24 (11) : 1708 - 1715
  • [3] Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial
    M L Subramanian
    G Abedi
    S Ness
    E Ahmed
    M Fenberg
    M K Daly
    A Houranieh
    E B Feinberg
    Eye, 2010, 24 : 1708 - 1715
  • [4] Response to comment on ‘Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial’
    M L Subramanian
    Eye, 2011, 25 : 820 - 820
  • [5] Response to comment on 'Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial'
    Wakefield, M. J.
    Tole, D. M.
    Bailey, C. C.
    Mundasad, M. V.
    Sparrow, J. M.
    EYE, 2011, 25 (06) : 821 - 821
  • [6] Bevacizumab for neovascular age-related macular degeneration (ABC trial): multicenter randomized double-masked study
    Ghazi, Nicola G.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2010, 3 (06) : 747 - 752
  • [7] A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD study)
    Holz, FG
    Engenhart-Cabillic, R
    Unnebrink, K
    Pritsch, M
    Bellmann, C
    Debus, J
    Völcker, HE
    Wannenmacher, M
    Schmitt, J
    Holle, R
    Müller, RP
    Wolfensberger, TJ
    Schütt, F
    Staudt, S
    Taufenbach, D
    Gross-Jendroska, M
    Potthöfer, S
    Bornfeld, N
    Kleineidam, M
    Behme, T
    Foerster, M
    Wiegel, T
    Hinkelbein, W
    Schönherr, U
    Amann, T
    Mardin, CY
    Naumann, GOH
    Schuchardt, U
    Keilholz, L
    Sauer, R
    Hansen, LL
    Scheuerbrandt, M
    Jahnknecht, P
    Schlunck, G
    Henne, K
    Frommhold, H
    Winter, R
    Steinhorst, U
    Steiner, M
    de Groot, H
    Placke, F
    Rades, D
    Karstens, JH
    Fuss, M
    Scheider, A
    Ulbig, MW
    Roesen, B
    Kampik, A
    Feldmann, KJ
    Grosu, AL
    OPHTHALMOLOGY, 1999, 106 (12) : 2239 - 2247
  • [8] A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration
    Krebs, Ilse
    Schmetterer, Leopold
    Boltz, Agnes
    Told, Reinhard
    Vecsei-Marlovits, Veronika
    Egger, Stefan
    Schoenherr, Ulrich
    Haas, Anton
    Ansari-Shahrezaei, Siamak
    Binder, Susanne
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (03) : 266 - 271
  • [9] Bevacizumab vs Ranibizumab: One Year Outcomes of a Head to Head, Prospective, Double-Masked, Randomized Clinical Trial
    Subramanian, M. L.
    Abedi, G.
    Ness, S.
    Feinberg, E. B.
    Fenberg, M. J.
    Daly, M.
    Houranieh, A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [10] Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 1
    Regillo, Carl D.
    Brown, David M.
    Abraham, Prema
    Yue, Huibin
    Ianchulev, Tsontcho
    Schneider, Susan
    Shams, Naveed
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (02) : 239 - 248